CATC Stock UPDATES Cambridge Bancorp (CATC) 44.4900 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cambridge Bancorp (CATC) 44.4900 $CATC

Cambridge Bancorp Reports Second Quarter Earnings
Business Wire - Tue Jul 22, 8:01AM CDT
Cambridge Bancorp (OTCBB: CATC) today reported unaudited net income of $3,641,000 for the second quarter of 2014 compared to $3,475,000 for the same quarter in 2013. The increase in earnings of $166,000 (4.8%) was attributable to growth in both net interest income and noninterest income, offset by an increase in noninterest expense. Diluted earnings per share were $0.92 for the second quarter of 2014 compared to $0.89 for the same quarter in 2013. For the six months ended June 30, 2014, unaudited net income was $7,152,000, an increase of $346,000 (5.1%) compared to $6,806,000 for the first half of 2013. Diluted earnings per share were $1.81 for the first six months of 2014 versus $1.75 for the same period in 2013.

Sarah G. Green Joins Board of Directors of Cambridge Trust Company
Business Wire - Fri Jun 20, 8:00AM CDT
Cambridge Bancorp and its subsidiary, Cambridge Trust Company, announced the appointment of Sarah (Sally) G. Green to its Board of Directors. Green was First Vice President and Chief Operating Officer at the Federal Reserve Bank of Richmond from 2006 - 2013. She had responsibility for the Bank's payments systems, outreach, financial management, information technology, and corporate support services.

Cambridge Bancorp President and CEO Joseph Roller Announces Mid-2015 Retirement Plans
Business Wire - Tue Jun 17, 9:30AM CDT
Cambridge Bancorp President and CEO Joseph V. Roller II announced today his plans to retire by mid-2015, setting the stage for the company's Board of Directors to begin the search for his successor. Roller has been with Cambridge Bancorp and its subsidiary, Cambridge Trust Company, since 2001 when he joined as President and Chief Operating Officer. In 2003, he was named CEO. Roller is the 11th president in the 124-year history of the Bank.

Cambridge Bancorp Announces Quarterly Dividend
Business Wire - Wed May 21, 12:05PM CDT
Cambridge Bancorp (OTCBB: CATC) announced that its Board of Directors has approved a quarterly dividend of $0.42 per share. The dividend is payable June 30, 2014 to shareholders of record as of June 10, 2014.

Cambridge Bancorp Announces Record Earnings for Full Year 2013
Business Wire - Tue Jan 28, 7:15AM CST
Cambridge Bancorp (OTCBB: CATC) today announced unaudited net income of $14,140,000 for the year ended December 31, 2013, representing an increase of $737,000, or 5.5%, compared to net income of $13,403,000 for the year ended December 31, 2012. Diluted earnings per share (EPS) were $3.62, a 4.9% increase over diluted earnings per share for the prior year.

Cambridge Bancorp Reports First Quarter Results
Business Wire - Mon Apr 22, 8:47AM CDT
Cambridge Bancorp (OTC BB: CATC) today reported unaudited net income of $3,331,000 for the first quarter of 2013 compared to $3,285,000 for the same quarter in 2012. The modest earnings increase of $46,000 (1.4%) was attributable to a combination of solid growth in noninterest income offset by lower net interest income and higher noninterest expense for the quarter ended March 31, 2013. Diluted earnings per share remained unchanged at $0.85 quarter-over-quarter.

Donald Briggs Joins Board of Directors of Cambridge Trust Company
Business Wire - Mon Feb 25, 1:04PM CST
Cambridge Bancorp and its subsidiary, Cambridge Trust Company, announced the appointment of Donald Briggs to its Board of Directors. Mr. Briggs is senior vice president - development for Federal Realty Investment Trust. Federal Realty Investment Trust is an equity real estate investment trust specializing in the ownership, management, and redevelopment of high quality retail real estate in the country's best markets. Mr. Briggs leads the planning and execution of the Trust's development and redevelopment projects.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading